Sylvie Marchand

3.2k total citations · 1 hit paper
24 papers, 2.3k citations indexed

About

Sylvie Marchand is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Sylvie Marchand has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cell Biology. Recurrent topics in Sylvie Marchand's work include Muscle Physiology and Disorders (12 papers), Cardiomyopathy and Myosin Studies (6 papers) and Calpain Protease Function and Regulation (5 papers). Sylvie Marchand is often cited by papers focused on Muscle Physiology and Disorders (12 papers), Cardiomyopathy and Myosin Studies (6 papers) and Calpain Protease Function and Regulation (5 papers). Sylvie Marchand collaborates with scholars based in France, Finland and Canada. Sylvie Marchand's co-authors include Isabelle Richard, Peter Hackman, Anna Vihola, J. Beckmann, Nathalie Bourg, Isabelle Richard, Bjarne Udd, Ilka Lowensteyn, Steven A. Grover and J. Sarparanta and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Sylvie Marchand

24 papers receiving 2.3k citations

Hit Papers

A gene related to Caenorhabditis elegans spermatogenesis ... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers

Sylvie Marchand
Adnan Y. Manzur United Kingdom
D. Gardner‐Medwin United Kingdom
John T. Sladky United States
Saeed Bohlega Saudi Arabia
Grace Yoon Canada
Dorit Lev Israel
Adnan Y. Manzur United Kingdom
Sylvie Marchand
Citations per year, relative to Sylvie Marchand Sylvie Marchand (= 1×) peers Adnan Y. Manzur

Countries citing papers authored by Sylvie Marchand

Since Specialization
Citations

This map shows the geographic impact of Sylvie Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Marchand more than expected).

Fields of papers citing papers by Sylvie Marchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Marchand. The network helps show where Sylvie Marchand may publish in the future.

Co-authorship network of co-authors of Sylvie Marchand

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Marchand. A scholar is included among the top collaborators of Sylvie Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Marchand. Sylvie Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laemmel, Elisabeth, Nicolas Segal, Massoud Mirshahi, et al.. (2016). Deleterious Effects of Intra-arterial Administration of Particulate Steroids on Microvascular Perfusion in a Mouse Model. Radiology. 279(3). 731–740. 37 indexed citations
2.
Mirshahi, Massoud & Sylvie Marchand. (2015). Co-purification of arrestin like proteins with alpha-enolase from bovine myocardial tissues and the possible role in heart diseases as an autoantigen. Biochemical and Biophysical Research Communications. 460(3). 657–662. 2 indexed citations
3.
Banack, Hailey R., Crystal Holly, Ilka Lowensteyn, et al.. (2014). The Association Between Sleep Disturbance, Depressive Symptoms, and Health-Related Quality of Life Among Cardiac Rehabilitation Participants. Journal of Cardiopulmonary Rehabilitation and Prevention. 34(3). 188–194. 30 indexed citations
4.
5.
Blandin, Gaëlle, Sylvie Marchand, Karine Charton, et al.. (2013). A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome. Skeletal Muscle. 3(1). 3–3. 36 indexed citations
6.
Banack, Hailey R., et al.. (2012). The MyHealthCheckup Study: Training Graduate Students to Implement Cardiovascular Risk Screening Programs in Community Pharmacies. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 145(6). 268–275. 1 indexed citations
7.
Grover, Steven A., et al.. (2011). Estimating the Benefits of Patient and Physician Adherence to Cardiovascular Prevention Guidelines: The MyHealthCheckup Survey. Canadian Journal of Cardiology. 27(2). 159–166. 15 indexed citations
8.
Sarparanta, J., Gaëlle Blandin, Karine Charton, et al.. (2010). Interactions with M-band Titin and Calpain 3 Link Myospryn (CMYA5) to Tibial and Limb-girdle Muscular Dystrophies. Journal of Biological Chemistry. 285(39). 30304–30315. 55 indexed citations
9.
Grover, Steven A., Ilka Lowensteyn, Lawrence Joseph, et al.. (2008). Discussing Coronary Risk with Patients to Improve Blood Pressure Treatment: Secondary Results from the CHECK-UP Study. Journal of General Internal Medicine. 24(1). 33–39. 20 indexed citations
10.
Hackman, Peter, Sylvie Marchand, J. Sarparanta, et al.. (2008). Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD). Neuromuscular Disorders. 18(12). 922–928. 72 indexed citations
11.
Carmignac, Virginie, Mustafa A. Salih, Susana Quijano‐Roy, et al.. (2007). C‐terminal titin deletions cause a novel early‐onset myopathy with fatal cardiomyopathy. Annals of Neurology. 61(4). 340–351. 156 indexed citations
12.
Grover, Steven A., Ilka Lowensteyn, Mohammed Kaouache, et al.. (2006). The Prevalence of Erectile Dysfunction in the Primary Care Setting. Archives of Internal Medicine. 166(2). 213–213. 198 indexed citations
13.
Lange, Stephan, Fengqing Xiang, Anna Vihola, et al.. (2005). The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover. Science. 308(5728). 1599–1603. 454 indexed citations
14.
Stockholm, Daniel, et al.. (2004). Bidirectional transcriptional activity of the Pgk1 promoter and transmission ratio distortion in Capn3-deficient mice. Genomics. 84(3). 592–595. 6 indexed citations
15.
Bergh, Peter Van den, Christine Verellen, Sylvie Marchand, et al.. (2003). Tibial muscular dystrophy in a Belgian family. Annals of Neurology. 54(2). 248–251. 60 indexed citations
16.
Marchand, Sylvie, et al.. (2003). Touch-down method for high-performance sequencing of polymerase chain reaction products. Analytical Biochemistry. 315(2). 270–272. 8 indexed citations
17.
Lalonde, Lyne, Katherine Gray‐Donald, Ilka Lowensteyn, et al.. (2002). Comparing the Benefits of Diet and Exercise in the Treatment of Dyslipidemia. Preventive Medicine. 35(1). 16–24. 36 indexed citations
18.
Hackman, Peter, Anna Vihola, Henna Haravuori, et al.. (2002). Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin. The American Journal of Human Genetics. 71(3). 492–500. 310 indexed citations
19.
Marchand, Sylvie, Gil Tchernia, C Hiesse, et al.. (1999). Human parvovirus B19 infection in organ transplant recipients. Clinical Transplantation. 13(1). 17–24. 67 indexed citations
20.
Bashir, Rumaisa, S. Britton, Tom Strachan, et al.. (1998). A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genetics. 20(1). 37–42. 526 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026